About Philip Johnson, M.D.
Form D filings for Interius BioTherapeutics from 2021 to 2024 list Philip Johnson, M.D. as president and chief executive officer, director.
Philip Johnson, M.D. first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Philip Johnson, M.D. in the role, so the role may have started earlier or lasted longer.
Interius BioTherapeutics, Inc.
President and Chief Executive Officer, director
2021 – 2024 · Philadelphia, PA
Key Colleagues at Startups
The people Philip Johnson, M.D. works with at each company, as listed on that company's latest Form D.
Interius BioTherapeutics, Inc. · Form D, Jun 3, 2024
LM
Leon Moulder
Director
TK
Tomas Kiselak
Director
BC
Bihua Chen
Director
LJ
Leon Moulder, Jr.
Director
DM
Dora Mitchell
Executive officer